Altimmune Inc
NASDAQ:ALT

Watchlist Manager
Altimmune Inc Logo
Altimmune Inc
NASDAQ:ALT
Watchlist
Price: 5.59 USD -4.44% Market Closed
Market Cap: 430.5m USD

EV/OCF
Enterprise Value to OCF

-3.4
Current
-4.4
Median
4.4
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-3.4
=
Enterprise Value
272.6m USD
/
Operating Cash Flow
-79.8m USD
 
US
Altimmune Inc
NASDAQ:ALT
Average EV/OCF: 19.4
Negative Multiple: -3.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 794.4
US
Abbvie Inc
NYSE:ABBV
23.3
US
Amgen Inc
NASDAQ:AMGN
15.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -107.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -512.2
AU
CSL Ltd
ASX:CSL
28.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -80.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -803.9

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A